270 related articles for article (PubMed ID: 29617289)
1. A Developed NK-92MI Cell Line with Siglec-7
Huang CH; Liao YJ; Fan TH; Chiou TJ; Lin YH; Twu YC
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617289
[TBL] [Abstract][Full Text] [Related]
2. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
[TBL] [Abstract][Full Text] [Related]
3. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.
Daly J; Carlsten M; O'Dwyer M
Front Immunol; 2019; 10():1047. PubMed ID: 31143186
[TBL] [Abstract][Full Text] [Related]
4. Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.
Jandus C; Boligan KF; Chijioke O; Liu H; Dahlhaus M; Démoulins T; Schneider C; Wehrli M; Hunger RE; Baerlocher GM; Simon HU; Romero P; Münz C; von Gunten S
J Clin Invest; 2014 Apr; 124(4):1810-20. PubMed ID: 24569453
[TBL] [Abstract][Full Text] [Related]
5. Branched I antigens on leukemia cells enhanced sensitivity against natural killer-cell cytotoxicity through affecting the target-effector interaction.
Lee YH; Liao YJ; Huang CH; Chang FL; Fan TH; Twu YC
Transfusion; 2017 Apr; 57(4):1040-1051. PubMed ID: 28337749
[TBL] [Abstract][Full Text] [Related]
6. Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.
Adeniji OS; Kuri-Cervantes L; Yu C; Xu Z; Ho M; Chew GM; Shikuma C; Tomescu C; George AF; Roan NR; Ndhlovu LC; Liu Q; Muthumani K; Weiner DB; Betts MR; Xiao H; Abdel-Mohsen M
PLoS Pathog; 2021 Nov; 17(11):e1010034. PubMed ID: 34762717
[TBL] [Abstract][Full Text] [Related]
7. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
[TBL] [Abstract][Full Text] [Related]
8. Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion.
Hudak JE; Canham SM; Bertozzi CR
Nat Chem Biol; 2014 Jan; 10(1):69-75. PubMed ID: 24292068
[TBL] [Abstract][Full Text] [Related]
9. TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.
Huang CH; Liao YJ; Chiou TJ; Huang HT; Lin YH; Twu YC
Immunobiology; 2019 Sep; 224(5):649-658. PubMed ID: 31421859
[TBL] [Abstract][Full Text] [Related]
10. Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication.
Zhao D; Jiang X; Xu Y; Yang H; Gao D; Li X; Gao L; Ma C; Liang X
Front Immunol; 2018; 9():1124. PubMed ID: 29899741
[TBL] [Abstract][Full Text] [Related]
11. Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell-mediated tumor responses.
Daly J; Sarkar S; Natoni A; Stark JC; Riley NM; Bertozzi CR; Carlsten M; O'Dwyer ME
Blood Adv; 2022 Jun; 6(11):3352-3366. PubMed ID: 35294519
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.
Shiozawa M; Chang CH; Huang YC; Chen YC; Chi MS; Hao HC; Chang YC; Takeda S; Chi KH; Wang YS
BMC Immunol; 2018 Aug; 19(1):27. PubMed ID: 30075754
[TBL] [Abstract][Full Text] [Related]
13. Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.
Tao L; Wang S; Yang L; Jiang L; Li J; Wang X
Clin Exp Immunol; 2020 Aug; 201(2):161-170. PubMed ID: 32319079
[TBL] [Abstract][Full Text] [Related]
14. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.
Penack O; Gentilini C; Fischer L; Asemissen AM; Scheibenbogen C; Thiel E; Uharek L
Leukemia; 2005 May; 19(5):835-40. PubMed ID: 15744340
[TBL] [Abstract][Full Text] [Related]
15. [Effect of demethylating treatment on cytotoxicity of NK-92MI cells].
Gao XN; Wang LL; Lin J; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):924-8. PubMed ID: 19698230
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms.
Nicoll G; Avril T; Lock K; Furukawa K; Bovin N; Crocker PR
Eur J Immunol; 2003 Jun; 33(6):1642-8. PubMed ID: 12778482
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation-mediated Siglec-7 regulation in natural killer cells via two 5' promoter CpG sites.
Huang HT; Su SC; Chiou TJ; Lin YH; Shih YC; Wu YX; Fan TH; Twu YC
Immunology; 2020 May; 160(1):38-51. PubMed ID: 32027025
[TBL] [Abstract][Full Text] [Related]
18. Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway.
Grabenstein S; Barnard KN; Anim M; Armoo A; Weichert WS; Bertozzi CR; Parrish CR; Willand-Charnley R
Glycobiology; 2021 Nov; 31(10):1279-1294. PubMed ID: 34192335
[TBL] [Abstract][Full Text] [Related]
19. Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection.
Varchetta S; Mele D; Lombardi A; Oliviero B; Mantovani S; Tinelli C; Spreafico M; Prati D; Ludovisi S; Ferraioli G; Filice C; Aghemo A; Lampertico P; Facchetti F; Bernuzzi F; Invernizzi P; Mondelli MU
Gut; 2016 Dec; 65(12):1998-2006. PubMed ID: 26674359
[TBL] [Abstract][Full Text] [Related]
20. Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.
Chen Y; You F; Jiang L; Li J; Zhu X; Bao Y; Sun X; Tang X; Meng H; An G; Zhang B; Yang L
Oncotarget; 2017 Jun; 8(23):37128-37139. PubMed ID: 28415754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
